New insight into the antiaggregant activity of furoxans
Authors:
- Nadezhda E. UstyuzhaninaNUNadezhda E. Ustyuzhanina
- Leonid L. FershtatLFLeonid L. Fershtat
- Marina L. GeningMGMarina L. Gening
- Nikolay E. NifantievNNNikolay E. Nifantiev
- Nina N. MakhovaNMNina N. Makhova
- 1 November 2016
- journal article
- Published by OOO Zhurnal "Mendeleevskie Soobshcheniya" in Mendeleev Communications
- Vol. 26 (6) , 513-515
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Furoxans (1,2,5-Oxadiazole-N-Oxides) as Novel NO Mimetic Neuroprotective and Procognitive AgentsJournal of Medicinal Chemistry, 2012
- Furoxan nitric oxide donor coupled chrysin derivatives: Synthesis and vasculoprotectionBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agentsBioorganic & Medicinal Chemistry Letters, 2010
- Unsymmetrically substituted furoxans. Part 19. Methyl and phenylfuroxansulfonic acids and related sulfonamidesJournal of Heterocyclic Chemistry, 2009
- Studies of the potential genotoxic effects of furoxans: The case of CAS 1609 and of the water-soluble analogue of CHF 2363Toxicology Letters, 2008
- Nitric Oxide Donor β2-Agonists: Furoxan Derivatives Containing the Fenoterol Moiety and Related FurazansJournal of Medicinal Chemistry, 2007
- Mechanism of action of novel NO‐releasing furoxan derivatives of aspirin in human plateletsBritish Journal of Pharmacology, 2006
- Vasorelaxant and antiplatelet activity of 4,7‐dimethyl‐1,2,5‐oxadiazolo[3,4‐d]pyridazine 1,5,6‐trioxide: role of soluble guanylate cyclase, nitric oxide and thiolsBritish Journal of Pharmacology, 2000
- ADP-lnduced Platelet ActivationCritical Reviews in Biochemistry and Molecular Biology, 1997
- No-Mimetic Furoxans: Arylsulphonylfuroxans and Related CompoundsPharmacological Research, 1993